|
1
|
Zong Y, Goldstein AS and Huang J: The
molecular basis for ethnic variation and histological subtype
differences in prostate cancer. Sci China Life Sci. 56:780–787.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Adlakha YK, Khanna S, Singh R, Singh VP,
Agrawal A and Saini N: Pro-apoptotic miRNA-128-2 modulates ABCA1,
ABCG1 and RXRα expression and cholesterol homeostasis. Cell Death
Dis. 4:e7802013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yue S, Li J, Lee SY, Lee HJ, Shao T, Song
B, Cheng L, Masterson TA, Liu X, Ratliff TL and Cheng JX:
Cholesteryl ester accumulation induced by PTEN loss and PI3K/AKT
activation underlies human prostate cancer aggressiveness. Cell
Metab. 19:393–406. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Stopsack KH, Gerke TA, Andrén O, Andersson
SO, Giovannucci EL, Mucci LA and Rider JR: Cholesterol uptake and
regulation in high-grade and lethal prostate cancers.
Carcinogenesis. 38:806–811. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cruz PM, Mo H, McConathy WJ, Sabnis N and
Lacko AG: The role of cholesterol metabolism and cholesterol
transport in carcinogenesis: A review of scientific findings,
relevant to future cancer therapeutics. Front Pharmacol. 4:1192013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Flores K, Manautou JE and Renfro JL:
Gender-specific expression of ATP-binding cassette (Abc)
transporters and cytoprotective genes in mouse choroid plexus.
Toxicology. 386:84–92. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Durmus S, Hendrikx JJ and Schinkel AH:
Apical ABC transporters and cancer chemotherapeutic drug
disposition. Adv Cancer Res. 125:1–41. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kaminski WE, Piehler A and Wenzel JJ: ABC
A-subfamily transporters: Structure, function and disease. Biochim
Biophys Acta. 1762:510–524. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Qian H, Zhao X, Cao P, Lei J, Yan N and
Gong X: Structure of the human lipid exporter ABCA1. Cell.
169:1228–1239.e10. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fitzgerald ML, Mendez AJ, Moore KJ,
Andersson LP, Panjeton HA and Freeman MW: ATP-binding cassette
transporter A1 contains an NH2-terminal signal anchor sequence that
translocates the protein's first hydrophilic domain to the
exoplasmic space. J Biol Chem. 276:15137–15145. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lamping E, Baret PV, Holmes AR, Monk BC,
Goffeau A and Cannon RD: Fungal PDR transporters: Phylogeny,
topology, motifs and function. Fungal Genet Biol. 47:127–142. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lund-Katz S and Phillips MC: High density
lipoprotein structure-function and role in reverse cholesterol
transport. Subcell Biochem. 51:183–227. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sene A, Khan AA, Cox D, Nakamura RE,
Santeford A, Kim BM, Sidhu R, Onken MD, Harbour JW, Hagbi-Levi S,
et al: Impaired cholesterol efflux in senescent macrophages
promotes age-related macular degeneration. Cell Metab. 17:549–561.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang S and Smith JD: ABCA1 and nascent HDL
biogenesis. Biofactors. 40:547–554. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Murano T, Yamaguchi T, Tatsuno I, Suzuki
M, Noike H, Takanami T, Yoshida T, Suzuki M, Hashimoto R, Maeno T,
et al: Subfraction analysis of circulating lipoproteins in a
patient with Tangier disease due to a novel ABCA1 mutation. Clin
Chim Acta. 452:167–172. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bi DP, Yin CH, Zhang XY, Yang NN and Xu
JY: MiR-183 functions as an oncogene by targeting ABCA1 in colon
cancer. Oncol Rep. 35:2873–2879. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sharma M, Tuaine J, McLaren B, Waters DL,
Black K, Jones LM and McCormick SP: Chemotherapy agents alter
plasma lipids in breast cancer patients and show differential
effects on lipid metabolism genes in liver cells. PLoS One.
11:e01480492016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kaneko T, Kanno C, Ichikawa-Tomikawa N,
Kashiwagi K, Yaginuma N, Ohkoshi C, Tanaka M, Sugino T, Imura T,
Hasegawa H and Chiba H: Liver X receptor reduces proliferation of
human oral cancer cells by promoting cholesterol efflux via
up-regulation of ABCA1 expression. Oncotarget. 6:33345–33357. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sviridov DO, Drake SK, Freeman LA and
Remaley AT: Amphipathic polyproline peptides stimulate cholesterol
efflux by the ABCA1 transporter. Biochem Biophys Res Commun.
471:560–565. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang M, Li L, Xie W, Wu JF, Yao F, Tan
YL, Xia XD, Liu XY, Liu D, Lan G, et al: Apolipoprotein A-1 binding
protein promotes macrophage cholesterol efflux by facilitating
apolipoprotein A-1 binding to ABCA1 and preventing ABCA1
degradation. Atherosclerosis. 248:149–159. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sultana A, Cochran BJ, Tabet F, Patel M,
Torres LC, Barter PJ and Rye KA: Inhibition of inflammatory
signaling pathways in 3T3-L1 adipocytes by apolipoprotein A-I.
FASEB J. 30:2324–2335. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Smith B and Land H: Anticancer activity of
the cholesterol exporter ABCA1 gene. Cell Rep. 2:580–590. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Her NG, Jeong SI, Cho K, Ha TK, Han J, Ko
KP, Park SK, Lee JH, Lee MG, Ryu BK and Chi SG: PPARδ promotes
oncogenic redirection of TGF-β1 signaling through the activation of
the ABCA1-Cav1 pathway. Cell Cycle. 12:1521–1535. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tazoe F, Yagyu H, Okazaki H, Igarashi M,
Eto K, Nagashima S, Inaba T, Shimano H, Osuga J and Ishibashi S:
Induction of ABCA1 by overexpression of hormone-sensitive lipase in
macrophages. Biochem Biophys Res Commun. 376:111–115. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Dufour J, Viennois E, De Boussac H, Baron
S and Lobaccaro JM: Oxysterol receptors, AKT and prostate cancer.
Curr Opin Pharmacol. 12:724–728. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chuu CP, Hiipakka RA, Kokontis JM, Fukuchi
J, Chen RY and Liao S: Inhibition of tumor growth and progression
of LNCaP prostate cancer cells in athymic mice by androgen and
liver X receptor agonist. Cancer Res. 66:6482–6486. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lee BH, Taylor MG, Robinet P, Smith JD,
Schweitzer J, Sehayek E, Falzarano SM, Magi-Galluzzi C, Klein EA
and Ting AH: Dysregulation of cholesterol homeostasis in human
prostate cancer through loss of ABCA1. Cancer Res. 73:1211–1218.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhao GJ, Yin K, Fu YC and Tang CK: The
interaction of ApoA-I and ABCA1 triggers signal transduction
pathways to mediate efflux of cellular lipids. Mol Med. 18:149–158.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tang C, Houston BA, Storey C and LeBoeuf
RC: Both STAT3 activation and cholesterol efflux contribute to the
anti-inflammatory effect of apoA-I/ABCA1 interaction in
macrophages. J Lipid Res. 57:848–857. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bochem AE, van der Valk FM, Tolani S,
Stroes ES, Westerterp M and Tall AR: Increased systemic and plaque
inflammation in ABCA1 mutation carriers with attenuation by
statins. Arterioscler Thromb Vasc Biol. 35:1663–1669. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ramírez CM, Lin CS, Abdelmohsen K, Goedeke
L, Yoon JH, Madrigal-Matute J, Martin-Ventura JL, Vo DT, Uren PJ,
Penalva LO, et al: RNA binding protein HuR regulates the expression
of ABCA1. J Lipid Res. 55:1066–1076. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ohno Y, Ohori M, Nakashima J, Okubo H,
Satake N, Hashimoto T and Tachibana M: Association between
preoperative serum total cholesterol level and biochemical
recurrence in prostate cancer patients who underwent radical
prostatectomy. Mol Clin Oncol. 4:1073–1077. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cardenas E and Ghosh R: Vitamin E: A dark
horse at the crossroad of cancer management. Biochem Pharmacol.
86:845–852. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kaminski WE, Piehler A, Püllmann K,
Porsch-Ozcürümez M, Duong C, Bared GM, Büchler C and Schmitz G:
Complete coding sequence, promoter region, and genomic structure of
the human ABCA2 gene and evidence for sterol-dependent regulation
in macrophages. Biochem Biophys Res Commun. 281:249–258. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Paolini A, Baldassarre A, Del Gaudio I and
Masotti A: Structural features of the ATP-Binding Cassette (ABC)
transporter ABCA3. Int J Mol Sci. 16:19631–19644. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kubo Y, Sekiya S, Ohigashi M, Takenaka C,
Tamura K, Nada S, Nishi T, Yamamoto A and Yamaguchi A: ABCA5
resides in lysosomes, and ABCA5 knockout mice develop lysosomal
disease-like symptoms. Mol Cell Biol. 25:4138–4149. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Broccardo C, Osorio J, Luciani MF, Schriml
LM, Prades C, Shulenin S, Arnould I, Naudin L, Lafargue C, Rosier
M, et al: Comparative analysis of the promoter structure and
genomic organization of the human and mouse ABCA7 gene encoding a
novel ABCA transporter. Cytogenet Cell Genet. 92:264–270. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Piehler A, Kaminski WE, Wenzel JJ,
Langmann T and Schmitz G: Molecular structure of a novel
cholesterol-responsive A subclass ABC transporter, ABCA9. Biochem
Biophys Res Commun. 295:408–416. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Maeß MB, Stolle K, Cullen P and Lorkowski
S: Evidence for an alternative genomic structure, mRNA and protein
sequence of human ABCA13. Gene. 515:298–307. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Marques RB, Aghai A, de Ridder CMA,
Stuurman D, Hoeben S, Boer A, Ellston RP, Barry ST, Davies BR,
Trapman J and van Weerden WM: High efficacy of combination therapy
Using PI3K/AKT inhibitors with androgen deprivation in prostate
cancer preclinical models. Eur Urol. 67:1177–1185. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Okoro EU, Guo Z and Yang H: Akt
isoform-dependent regulation of ATP-Binding cassette A1 expression
by apolipoprotein E. Biochem Biophys Res Commun. 477:123–128. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Gabitova L, Restifo D, Gorin A, Manocha K,
Handorf E, Yang DH, Cai KQ, Klein-Szanto AJ, Cunningham D, Kratz
LE, et al: Endogenous sterol metabolites regulate growth of
EGFR/KRAS-dependent tumors via LXR. Cell Rep. 12:1927–1938. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Solomon KR, Allott EH, Freeman MR and
Freedland SJ: Words of wisdom. Re: Dysregulation of cholesterol
homeostasis in human prostate cancer through loss of ABCA1. Eur
Urol. 63:1128–1129. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Hayashi N, Matsushima M, Yamamoto T,
Sasaki H, Takahashi H and Egawa S: The impact of
hypertriglyceridemia on prostate cancer development in patients
aged ≥60 years. BJU Int. 109:515–519. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Chou JL, Huang RL, Shay J, Chen LY, Lin
SJ, Yan PS, Chao WT, Lai YH, Lai YL, Chao TK, et al:
Hypermethylation of the TGF-β target, ABCA1 is associated with poor
prognosis in ovarian cancer patients. Clin Epigenetics. 7:12015.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
He C and Klionsky DJ: Regulation
mechanisms and signaling pathways of autophagy. Annu Rev Genet.
43:67–93. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Puri P and Chandra A: Autophagy modulation
as a potential therapeutic target for liver diseases. J Clin Exp
Hepatol. 4:51–59. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Han XB, Li HX, Jiang YQ, Wang H, Li XS,
Kou JY, Zheng YH, Liu ZN, Li H, Li J, et al: Upconversion
nanoparticle-mediated photodynamic therapy induces autophagy and
cholesterol efflux of macrophage-derived foam cells via ROS
generation. Cell Death Dis. 8:e28642017. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Lin XL, Liu MH, Hu HJ, Feng HR, Fan XJ,
Zou WW, Pan YQ, Hu XM and Wang Z: Curcumin enhanced cholesterol
efflux by upregulating ABCA1 expression through AMPK-SIRT1-LXRα
signaling in THP-1 macrophage-derived foam cells. DNA Cell Biol.
34:561–572. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Jiang Y, Kou J, Han X, Li X, Zhong Z, Liu
Z, Zheng Y, Tian Y and Yang L: ROS-dependent activation of
autophagy through the PI3K/Akt/mTOR pathway is induced by
hydroxysafflor yellow A-sonodynamic therapy in THP-1 macrophages.
Oxid Med Cell Longev. 2017:85191692017. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Wu X, Daniels G, Lee P and Monaco ME:
Lipid metabolism in prostate cancer. Am J Clin Exp Urol. 2:111–120.
2014.PubMed/NCBI
|
|
52
|
Brusselmans K, Timmermans L, Van de Sande
T, Van Veldhoven PP, Guan G, Shechter I, Claessens F, Verhoeven G
and Swinnen JV: Squalene synthase, a determinant of Raft-associated
cholesterol and modulator of cancer cell proliferation. J Biol
Chem. 282:18777–18785. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Wang H, Jia XH, Chen JR, Yi YJ, Wang JY,
Li YJ and Xie SY: HOXB4 knockdown reverses multidrug resistance of
human myelogenous leukemia K562/ADM cells by downregulating P-gp,
MRP1 and BCRP expression via PI3K/Akt signaling pathway. Int J
Oncol. 49:2529–2537. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Chen JR, Jia XH, Wang H, Yi YJ, Wang JY
and Li YJ: Timosaponin A-III reverses multi-drug resistance in
human chronic myelogenous leukemia K562/ADM cells via
downregulation of MDR1 and MRP1 expression by inhibiting PI3K/Akt
signaling pathway. Int J Oncol. 48:2063–2070. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Mo W, Zhang J, Li X, Meng D, Gao Y, Yang
S, Wan X, Zhou C, Guo F, Huang Y, et al: Identification of novel
AR-targeted microRNAs mediating androgen signalling through
critical pathways to regulate cell viability in prostate cancer.
PLoS One. 8:e565922013. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Sekine Y, Demosky SJ, Stonik JA, Furuya Y,
Koike H, Suzuki K and Remaley AT: High-density lipoprotein induces
proliferation and migration of human prostate androgen-independent
cancer cells by an ABCA1-dependent mechanism. Mol Cancer Res.
8:1284–1294. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Chisaki I, Kobayashi M, Itagaki S, Hirano
T and Iseki K: Liver X receptor regulates expression of MRP2 but
not that of MDR1 and BCRP in the liver. Biochim Biophys Acta.
1788:2396–2403. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Kimura Y, Morita SY, Matsuo M and Ueda K:
Mechanism of multidrug recognition by MDR1/ABCB1. Cancer Sci.
98:1303–1310. 2007. View Article : Google Scholar : PubMed/NCBI
|
